Ceramide and phosphatidylcholine lipids‐based risk score predicts major cardiovascular outcomes in patients with heart failure
The CERT2 risk score is strongly associated with an increased risk of CV death, all-cause death and MACE in patients with HF.
Authors
- Marianna Cerrato (ORCID: https://orcid.org/0009-0007-6254-8337)
- Mika Hilvo (ORCID: https://orcid.org/0000-0003-0663-5843)
- Nicolas Girerd (ORCID: https://orcid.org/0000-0002-3278-2057)
- Patrick Rossignol (ORCID: https://orcid.org/0000-0001-8009-3873)
- Deborah Novelli (ORCID: https://orcid.org/0000-0002-2749-304X)
- Kévin Duarte (ORCID: https://orcid.org/0000-0002-0292-0498)
- Roberto Latini (ORCID: https://orcid.org/0000-0002-3729-4650)
- Jennifer Meessen (ORCID: https://orcid.org/0000-0002-1744-6899)
- Reijo Laaksonen (ORCID: https://orcid.org/0000-0001-9888-4278)
- Giovanni Targher (ORCID: https://orcid.org/0000-0002-4325-3900)
- Antti Jylhä (ORCID: https://orcid.org/0000-0002-9910-1017)
- Faı̈ez Zannad (ORCID: https://orcid.org/0000-0001-7456-1570)
- Angelika Witoslawska (ORCID: https://orcid.org/0000-0003-0733-652X)
Institutions
- University of Verona (IT)
- Tampere University (FI)
- Mario Negri Institute for Pharmacological Research (IT)
- Zora Biosciences (Finland) (FI)
- Ospedale Sacro Cuore Don Calabria (IT)
- Tampere University (FI)
- Centre d'Investigation Clinique Pierre Drouin (FR)
- VTT Technical Research Centre of Finland (FI)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1111/eci.14359
- Citations
- 2
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- European Commission
- Regione Lombardia
- Fondazione Regionale per la Ricerca Biomedica
- HORIZON EUROPE Framework Programme